A single treatment with a fluralaner injectable suspension (Bravecto® injectable) provides 1-year efficacy against Rhipicephalus sanguineus sensu lato and Ctenocephalides felis in dogs
The fluralaner injectable suspension (Bravecto<sup>®</sup> injectable) provides 1 year of efficacy against R. sanguineus s.l. and C. felis infestations in dogs following a single treatment, allowing once-yearly treatment, which can significantly improve owner compliance with year-round protection of dogs.
Authors
- Katharina Raue
- Ivo Petersen
- Anna Schwarz (ORCID: https://orcid.org/0000-0003-3825-5538)
- Eva Zschiesche
- Christina Strübe (ORCID: https://orcid.org/0000-0002-9093-1006)
- Marie-Kristin Raulf (ORCID: https://orcid.org/0000-0001-8967-6741)
- Lea Heinau
Institutions
- University of Veterinary Medicine Hannover, Foundation (DE)
Publication Details
- Journal
- Parasites & Vectors
- Published
- 2024-10-26
- DOI
- https://doi.org/10.1186/s13071-024-06535-8
- Citations
- 2
- Primary Topic
- Vector-borne infectious diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.03